Clinical Report: TREM1 Drives Immunosuppression in Glioma
Overview
This study investigates the role of TREM1 in glioma, highlighting its association with tumor-associated macrophages (TAMs). The findings indicate that TREM1 promotes M2 macrophage polarization.
Background
Glioblastoma (GBM) is a highly aggressive brain tumor with poor patient outcomes despite current treatment modalities. Tumor-associated macrophages (TAMs) are the predominant immune cell type in the glioma microenvironment and play a crucial role in tumor progression and immune suppression.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
TREM1 expression is upregulated in glioma, particularly in more malignant subtypes.
TREM1 is associated with M2-type macrophages and promotes their polarization.
Knockdown of TREM1 in macrophages reduces glioma cell proliferation, invasion, and migration.
Clinical Implications
Further research is warranted to explore the potential of TREM1 in glioma.
Conclusion
TREM1 plays a significant role in promoting M2 macrophage polarization in glioma.
